Cover Image
市場調查報告書

醫療分析實驗服務的全球市場 - 至2023年的預測:分析法驗證,環境監測,生物分析服務,穩定性,原料,微生物實驗

Healthcare Analytical Testing Services Market by Type (Method Validation, Environmental Monitoring, Bioanalytical Services, Stability, Raw Materials, Microbial Testing), End User (Pharmaceutical, Medical Device Companies, CRO) - Global Forecast to 2023

出版商 MarketsandMarkets 商品編碼 359267
出版日期 內容資訊 英文 298 Pages
訂單完成後即時交付
價格
Back to Top
醫療分析實驗服務的全球市場 - 至2023年的預測:分析法驗證,環境監測,生物分析服務,穩定性,原料,微生物實驗 Healthcare Analytical Testing Services Market by Type (Method Validation, Environmental Monitoring, Bioanalytical Services, Stability, Raw Materials, Microbial Testing), End User (Pharmaceutical, Medical Device Companies, CRO) - Global Forecast to 2023
出版日期: 2018年03月20日 內容資訊: 英文 298 Pages
簡介

醫療分析實驗服務市場,預計從2018年的34億3000萬美元,到2022年擴大到59億7000萬美元。預計市場2018年∼2023年以11.7%的年複合成長率成長。

本報告提供全球醫療分析實驗服務市場相關調查分析,市場概要,產業趨勢,各市場區隔的市場分析,競爭情形,主要企業等相關的系統性資訊。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 重要考察

  • 醫療分析實驗服務市場概要
  • 亞太地區 - 醫療分析實驗服務市場:各終端用戶、各國
  • 醫療分析實驗服務市場:各地區概述
  • 醫療分析實驗服務市場:地區結構

第5章 市場概要

  • 簡介
  • 市場動態
    • 促進因素
    • 阻礙因素
    • 機會
    • 課題

第6章 產業考察

  • 產業趨勢
  • 法規分析

第7章 醫療分析實驗服務的全球市場:各類型

  • 簡介
  • 生物分析實驗
  • 物理的特性評估
  • 分析法的開發、驗證
  • 原料實驗
  • 順利地租賃實驗
  • 穩定性實驗
  • 微生物實驗
  • 環境監測

第8章 醫療分析實驗服務的全球市場:各終端用戶

  • 簡介
  • 製藥、生物醫藥品企業
  • 醫療設備企業
  • CRO

第9章 醫療分析實驗服務的全球市場:各地區

  • 簡介
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東、非洲

第10章 競爭情形

  • 概要
  • 市場佔有率分析
  • 競爭模式

第11章 企業簡介

  • EUROFINS SCIENTIFIC
  • LABCORP
  • SGS
  • CHARLES RIVER
  • WUXI PHARMATECH
  • PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC (PPD)
  • EXOVA
  • PACE ANALYTICAL
  • ENVIGO
  • INTERTEK
  • MPI RESEARCH
  • MERCK KGAA
  • SOURCE BIOSCIENCE

第12章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: AST 4341

"The global healthcare analytical testing services market projected to grow at a CAGR of 11.7%."

The healthcare analytical testing services market is expected to reach USD 5.97 billion by 2023 from an estimated USD 3.43 billion in 2018, at a CAGR of 11.7%. The shift of focus towards analytical testing of biologics and biosimilars, increasing outsourcing of analytical testing by pharmaceutical companies, increasing acceptance of the QbD approach in pharma research/manufacturing, and adoption of FTE contracts in R&D outsourcing are the major factors driving the growth of the healthcare analytical testing services market. However, factors such as the pricing pressure faced by market players and shortage of skilled professionals in the healthcare analytical testing services industry are limiting the adoption of healthcare analytical testing services up to some extent during the forecast period.

"The batch-release testing segment is expected to register the highest CAGR during the forecast period."

On the basis of type, the healthcare analytical testing services market is segmented into bioanalytical testing, physical characterization, method development and validation, raw material testing, stability testing, batch release testing, microbial testing, and environmental monitoring. The batch-release testing segment is expected to register the highest CAGR during the forecast period. The high growth rate of this segment is mainly due to the stringent regulations that require batch-release testing to be conducted for products marketed. In addition, the growing generic pharmaceuticals industry is further expected to drive the growth of this market.

"Pharmaceutical & biopharmaceutical companies segment expected to grow at the highest CAGR during 2018 to 2023."

Based on end user, the healthcare analytical testing services market is segmented into pharmaceutical & biopharmaceutical companies, medical device companies and contract research organizations. The pharmaceutical & biopharmaceutical companies segment is the fastest-growing end-user segment in the healthcare analytical testing services market during the forecast period. The growing pressure on drug manufacturers to deliver high-quality products and increasing outsourcing of analytical testing services are the major factors driving the growth of the healthcare analytical testing services market for pharmaceutical & biopharmaceutical companies.

"APAC is projected to witness the highest growth during the forecast period."

North America held the largest share of the global healthcare analytical testing services market in 2017. On the other hand, the APAC region is expected to witness the highest CAGR during the forecast period, due to the increasing R&D funding, growing number of CROs, and favorable government initiatives to promote pharmaceutical and biopharmaceutical industries in several APAC countries.

Break of primary participants was as mentioned below:

  • By Company Type - Tier 1-28%, Tier 2-43% and Tier 3-29%
  • By Designation - C-level-14%, Director Level-43%, Others-43%
  • By Region - North America-43%, Europe-14%, Asia Pacific-29%, Rest of World-14%

The prominent players in the global healthcare analytical testing services market are Eurofins Scientific (Luxembourg), Charles River Laboratories (US), Almac Group (UK), Exova Group (UK), PPD (US), Source BioScience (UK), Anabiotec (Belgium), Intertek Group (UK), Wuxi PharmaTech (China), and BioReliance (US).

Research Coverage:

The report analyzes the various healthcare analytical testing services and their adoption pattern. It aims at estimating the market size and future growth potential of the global healthcare analytical testing services market for different segments such as by type, end user, and region. The report also includes an in-depth competitive analysis of the key players in this market along with their company profiles, product offerings, recent developments, and key market strategies.

Reasons to Buy the Report:

The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a greater share. Firms purchasing the report could use one or any combination of the below-mentioned five strategies for strengthening the market.

This report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on product portfolios offered by the top players in the global healthcare analytical testing services market. The report analyzes the global healthcare analytical testing services market by type, end user, and region
  • Service Development/Innovation: Detailed insights on upcoming trends and service launches in the global healthcare analytical testing services market
  • Market Development: Comprehensive information on the lucrative emerging regions by type, end user, and region
  • Market Diversification: Exhaustive information about new services, growing geographies, and recent developments in the global healthcare analytical testing services market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, and services of leading players in the global healthcare analytical testing services market

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKETS COVERED
  • 1.4 YEARS CONSIDERED FOR THE STUDY
  • 1.5 CURRENCY
  • 1.6 STAKEHOLDERS

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
      • 2.1.2.1 Key data from primary sources
      • 2.1.2.2 Breakdown of primary
      • 2.1.2.3 Key industry insights
  • 2.2 MARKET SIZE ESTIMATION
    • 2.2.1 BOTTOM-UP APPROACH
    • 2.2.2 TOP-DOWN APPROACH
  • 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.4 ASSUMPTIONS FOR THE STUDY
  • 2.5 LIMITATIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET OVERVIEW
  • 4.2 APAC: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER & COUNTRY
  • 4.3 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: GEOGRAPHICAL SNAPSHOT
  • 4.4 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: GEOGRAPHICAL MIX

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Focus on analytical testing of biologics and biosimilars
      • 5.2.1.2 Increasing preference for outsourcing analytical testing
      • 5.2.1.3 Rising adoption of the Quality by Design approach
      • 5.2.1.4 Adoption of FTE contracts in R&D outsourcing
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Pricing pressure faced by major players
      • 5.2.2.2 Shortage of skilled professionals
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Rising demand for specialized analytical testing services
      • 5.2.3.2 Growth opportunities in emerging Asia Pacific countries
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Innovative formulations and medical devices demanding a unique analytical testing approach
      • 5.2.4.2 Development of appropriate dissolution methods
      • 5.2.4.3 Growing need to improve the sensitivity of analytical methods

6 INDUSTRY INSIGHTS

  • 6.1 INDUSTRY TRENDS
    • 6.1.1 GROWING INDUSTRY CONSOLIDATION
    • 6.1.2 LONG-TERM OUTSOURCING AND PREFERRED VENDOR PARTNERSHIPS
  • 6.2 REGULATORY ANALYSIS

7 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE

  • 7.1 INTRODUCTION
  • 7.2 BIOANALYTICAL TESTING
    • 7.2.1 CELL-BASED ASSAYS
    • 7.2.2 VIROLOGY TESTING
      • 7.2.2.1 In vitro assays
      • 7.2.2.2 In vivo assays
      • 7.2.2.3 Species-specific viral PCR assays
    • 7.2.3 IMMUNOGENICITY & NEUTRALIZING ANTIBODY TESTING
    • 7.2.4 BIOMARKER TESTING
    • 7.2.5 PHARMACOKINETIC TESTING
  • 7.3 PHYSICAL CHARACTERIZATION
    • 7.3.1 LASER PARTICLE SIZE ANALYSIS
    • 7.3.2 THERMAL ANALYSIS
    • 7.3.3 IMAGE ANALYSIS
    • 7.3.4 SURFACE AREA ANALYSIS
    • 7.3.5 OTHER PHYSICAL CHARACTERIZATION ANALYSIS SERVICES
  • 7.4 METHOD DEVELOPMENT & VALIDATION
    • 7.4.1 EXTRACTABLES & LEACHABLES METHOD DEVELOPMENT & VALIDATION
    • 7.4.2 PROCESS IMPURITY METHOD DEVELOPMENT & VALIDATION
    • 7.4.3 STABILITY INDICATING METHOD VALIDATION
    • 7.4.4 CLEANING VALIDATION METHOD DEVELOPMENT
    • 7.4.5 ANALYTICAL STANDARD CHARACTERIZATION
    • 7.4.6 TECHNICAL CONSULTING
    • 7.4.7 OTHER METHOD VALIDATION SERVICES
  • 7.5 RAW MATERIAL TESTING
    • 7.5.1 COMPLETE COMPENDIAL TESTING
    • 7.5.2 HEAVY METAL TESTING
    • 7.5.3 CONTAINER TESTING
    • 7.5.4 KARL FISCHER ANALYSIS
    • 7.5.5 WET CHEMISTRY ANALYSIS
    • 7.5.6 OTHER RAW MATERIAL TESTING SERVICES
  • 7.6 BATCH-RELEASE TESTING
    • 7.6.1 DISSOLUTION TESTING
    • 7.6.2 ELEMENTAL IMPURITY TESTING
    • 7.6.3 DISINTEGRATION TESTING
    • 7.6.4 HARDNESS TESTING
    • 7.6.5 FRIABILITY TESTING
    • 7.6.6 OTHER BATCH-RELEASE TESTING SERVICES
  • 7.7 STABILITY TESTING
    • 7.7.1 DRUG SUBSTANCE STABILITY TESTING
    • 7.7.2 FORMULATION EVALUATION STABILITY TESTING
    • 7.7.3 ACCELERATED STABILITY TESTING
    • 7.7.4 PHOTOSTABILITY TESTING
    • 7.7.5 COMPARATIVE STABILITY TESTING
    • 7.7.6 OTHER STABILITY TESTING SERVICES
  • 7.8 MICROBIAL TESTING
    • 7.8.1 MICROBIAL LIMIT TESTING
    • 7.8.2 STERILITY TESTING
    • 7.8.3 ENDOTOXIN TESTING
    • 7.8.4 PRESERVATIVE EFFICACY TESTING
    • 7.8.5 WATER TESTING
    • 7.8.6 OTHER MICROBIAL TESTING SERVICES
  • 7.9 ENVIRONMENTAL MONITORING
    • 7.9.1 AIR TESTING
    • 7.9.2 WASTEWATER/ETP TESTING
    • 7.9.3 OTHER ENVIRONMENTAL MONITORING SERVICES

8 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER

  • 8.1 INTRODUCTION
  • 8.2 PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES
  • 8.3 MEDICAL DEVICE COMPANIES
  • 8.4 CONTRACT RESEARCH ORGANIZATIONS

9 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY REGION

  • 9.1 INTRODUCTION
  • 9.2 NORTH AMERICA
    • 9.2.1 US
    • 9.2.2 CANADA
  • 9.3 EUROPE
    • 9.3.1 GERMANY
    • 9.3.2 UK
    • 9.3.3 FRANCE
    • 9.3.4 ITALY
    • 9.3.5 SWITZERLAND
    • 9.3.6 REST OF EUROPE
  • 9.4 ASIA PACIFIC
    • 9.4.1 CHINA
    • 9.4.2 JAPAN
    • 9.4.3 INDIA
    • 9.4.4 REST OF ASIA PACIFIC
  • 9.5 LATIN AMERICA
  • 9.6 MIDDLE EAST & AFRICA

10 COMPETITIVE LANDSCAPE

  • 10.1 OVERVIEW
  • 10.2 MARKET SHARE ANALYSIS
  • 10.3 COMPETITIVE SCENARIO
    • 10.3.1 ACQUISITIONS
    • 10.3.2 EXPANSIONS
    • 10.3.3 PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS
    • 10.3.4 SERVICES LAUNCHES

11 COMPANY PROFILES

(Business Overview, Services Offered, Recent Developments, SWOT Analysis, and MnM View)*

  • 11.1 EUROFINS SCIENTIFIC
  • 11.2 LABCORP
  • 11.3 SGS
  • 11.4 CHARLES RIVER
  • 11.5 WUXI PHARMATECH
  • 11.6 PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC (PPD)
  • 11.7 EXOVA
  • 11.8 PACE ANALYTICAL
  • 11.9 ENVIGO
  • 11.10 INTERTEK
  • 11.11 MPI RESEARCH
  • 11.12 MERCK KGAA
  • 11.13 SOURCE BIOSCIENCE

Details on Business Overview, Services Offered, Recent Developments, SWOT Analysis, and MnM View might not be captured in case of unlisted companies.

12 APPENDIX

  • 12.1 INSIGHTS OF INDUSTRY EXPERTS
  • 12.2 DISCUSSION GUIDE
  • 12.3 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.4 AVAILABLE CUSTOMIZATIONS
  • 12.5 RELATED REPORTS
  • 12.6 AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: BIOLOGICS FACING PATENT EXPIRY IN THE US/EU
  • TABLE 2: DRIVERS: IMPACT ANALYSIS
  • TABLE 3: RESTRAINTS: MARKET IMPACT
  • TABLE 4: OPPORTUNITIES: MARKET IMPACT
  • TABLE 5: CHALLENGES: MARKET IMPACT
  • TABLE 6: ICH QUALITY GUIDELINES FOR PHARMACEUTICAL GMP
  • TABLE 7: DEVELOPMENT OF GLP ACROSS COUNTRIES
  • TABLE 8: OVERVIEW OF GUIDELINES OF LABORATORY SERVICES
  • TABLE 9: REGULATORY AUTHORITIES AND LAUNCH OF GLP MONITORING PROGRAMS IN EUROPEAN COUNTRIES
  • TABLE 10: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 11: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 12: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 13: BIOANALYTICAL TESTING SERVICES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 14: CELL-BASED ASSAY SERVICES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 15: VIROLOGY TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 16: VIROLOGY TESTING SERVICES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 17: IN VITRO ASSAY SERVICES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 18: IN VIVO ASSAY SERVICES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 19: SPECIES-SPECIFIC VIRAL PCR ASSAY SERVICES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 20: IMMUNOGENICITY & NEUTRALIZING ANTIBODY TESTING SERVICES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 21: BIOMARKER TESTING SERVICES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 22: DISTRIBUTION OF NEW MOLECULAR ENTITIES, BY PHASE
  • TABLE 23: PHARMACOKINETIC TESTING SERVICES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 24: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 25: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 26: LASER PARTICLE SIZE ANALYSIS SERVICES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 27: THERMAL ANALYSIS SERVICES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 28: IMAGE ANALYSIS SERVICES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 29: SURFACE AREA ANALYSIS SERVICES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 30: OTHER PHYSICAL CHARACTERIZATION ANALYSIS SERVICES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 31: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 32: METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 33: EXTRACTABLES & LEACHABLES METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 34: PROCESS IMPURITY METHOD DEVELOPMENT & VALIDATION SERVICES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 35: STABILITY INDICATING METHOD VALIDATION SERVICES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 36: CLEANING VALIDATION METHOD DEVELOPMENT SERVICES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 37: ANALYTICAL STANDARD CHARACTERIZATION SERVICES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 38: TECHNICAL CONSULTING SERVICES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 39: OTHER METHOD VALIDATION SERVICES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 40: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 41: RAW MATERIAL TESTING SERVICES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 42: COMPLETE COMPENDIAL TESTING SERVICES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 43: HEAVY METAL TESTING SERVICES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 44: CHARACTERISTICS OF MAJOR CCI TESTING METHODS
  • TABLE 45: CONTAINER TESTING SERVICES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 46: KARL FISCHER ANALYSIS SERVICES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 47: WET CHEMISTRY ANALYSIS SERVICES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 48: OTHER RAW MATERIAL TESTING SERVICES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 49: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 50: BATCH-RELEASE TESTING SERVICES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 51: EVOLUTION OF FDA GUIDELINES FOR DISSOLUTION TESTING
  • TABLE 52: DISSOLUTION TESTING SERVICES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 53: ICH PERMITTED DAILY EXPOSURE FOR ELEMENTAL IMPURITIES
  • TABLE 54: ELEMENTAL IMPURITY TESTING SERVICES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 55: USP 32 DISINTEGRATION METHOD AND IMMERSION MEDIA INFORMATION
  • TABLE 56: DISINTEGRATION TESTING SERVICES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 57: HARDNESS TESTING SERVICES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 58: FRIABILITY TESTING SERVICES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 59: OTHER BATCH-RELEASE TESTING SERVICES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 60: STABILITY TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 61: STABILITY TESTING SERVICES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 62: DRUG SUBSTANCE STABILITY TESTING SERVICES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 63: FORMULATION EVALUATION STABILITY TESTING SERVICES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 64: ACCELERATED STABILITY STUDY CONDITION
  • TABLE 65: ACCELERATED STABILITY TESTING SERVICES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 66: PHOTOSTABILITY TESTING SERVICES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 67: COMPARATIVE STABILITY TESTING SERVICES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 68: OTHER STABILITY TESTING SERVICES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 69: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 70: MICROBIAL TESTING SERVICES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 71: STANDARD LIMIT FOR MICROBIAL LIMIT TESTING
  • TABLE 72: MICROBIAL LIMIT TESTING SERVICES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 73: STERILITY TESTING SERVICES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 74: ENDOTOXIN TESTING SERVICES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 75: PRESERVATIVE EFFICACY TESTING SERVICES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 76: STANDARDIZED LIMITS FOR WATER TESTING
  • TABLE 77: WATER TESTING SERVICES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 78: OTHER MICROBIAL TESTING SERVICES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 79: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 80: ENVIRONMENTAL MONITORING SERVICES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 81: PURITY CLASSES FOR PARTICLES, WATER, AND OIL IN COMPRESSED AIR
  • TABLE 82: AIR TESTING SERVICES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 83: STANDARDS FOR WASTEWATER QUALITY
  • TABLE 84: WASTEWATER/ETP TESTING SERVICES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 85: OTHER ENVIRONMENTAL MONITORING SERVICES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 86: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 87: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 88: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET FOR MEDICAL DEVICE COMPANIES, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 89: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 90: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 91: NORTH AMERICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 92: NORTH AMERICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 93: NORTH AMERICA: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 94: NORTH AMERICA: PHYSICAL CHARACTERIZATION TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 95: NORTH AMERICA: METHOD DEVELOPMENT AND VALIDATION SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 96: NORTH AMERICA: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 97: NORTH AMERICA: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 98: NORTH AMERICA: STABILITY TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 99: NORTH AMERICA: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 100: NORTH AMERICA: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 101: NORTH AMERICA: VIROLOGY TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 102: NORTH AMERICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 103: US: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 104: US: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 105: US: PHYSICAL CHARACTERIZATION TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 106: US: METHOD DEVELOPMENT AND VALIDATION SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 107: US: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 108: US: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 109: US: STABILITY TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 110: US: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 111: US: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 112: US: VIROLOGY TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 113: US: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 114: CANADA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 115: CANADA: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 116: CANADA: PHYSICAL CHARACTERIZATION TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 117: CANADA: METHOD DEVELOPMENT AND VALIDATION SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 118: CANADA: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 119: CANADA: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 120: CANADA: STABILITY TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 121: CANADA: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 122: CANADA: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 123: CANADA: VIROLOGY TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 124: CANADA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 125: EUROPE: PHARMACEUTICAL R&D EXPENDITURE AND PRODUCTION, BY COUNTRY (2015)
  • TABLE 126: EUROPE: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 127: EUROPE: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 128: EUROPE: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 129: EUROPE: PHYSICAL CHARACTERIZATION TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 130: EUROPE: METHOD DEVELOPMENT AND VALIDATION SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 131: EUROPE: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 132: EUROPE: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 133: EUROPE: STABILITY TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 134: EUROPE: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 135: EUROPE: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 136: EUROPE: VIROLOGY TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 137: EUROPE: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 138: GERMANY: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 139: GERMANY: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 140: GERMANY: PHYSICAL CHARACTERIZATION TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 141: GERMANY: METHOD DEVELOPMENT AND VALIDATION SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 142: GERMANY: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 143: GERMANY: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 144: GERMANY: STABILITY TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 145: GERMANY: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 146: GERMANY: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 147: GERMANY: VIROLOGY TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 148: GERMANY: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 149: UK: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 150: UK: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2 016-2023 (USD MILLION)
  • TABLE 151: UK: PHYSICAL CHARACTERIZATION TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 152: UK: METHOD DEVELOPMENT AND VALIDATION SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 153: UK: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 154: UK: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 155: UK: STABILITY TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 156: UK: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 157: UK: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 158: UK: VIROLOGY TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 159: UK: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 160: FRANCE: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 161: FRANCE: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 162: FRANCE: PHYSICAL CHARACTERIZATION TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 163: FRANCE: METHOD DEVELOPMENT AND VALIDATION SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 164: FRANCE: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 165: FRANCE: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 166: FRANCE: STABILITY TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 167: FRANCE: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 168: FRANCE: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 169: FRANCE: VIROLOGY TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 170: FRANCE: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 171: ITALY: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 172: ITALY: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 173: ITALY: PHYSICAL CHARACTERIZATION TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 174: ITALY: METHOD DEVELOPMENT AND VALIDATION SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 175: ITALY: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 176: ITALY: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 177: ITALY: STABILITY TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 178: ITALY: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 179: ITALY: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 180: ITALY: VIROLOGY TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 181: ITALY: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 182: SWITZERLAND: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 183: SWITZERLAND: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 184: SWITZERLAND: PHYSICAL CHARACTERIZATION TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 185: SWITZERLAND: METHOD DEVELOPMENT AND VALIDATION SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 186: SWITZERLAND: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 187: SWITZERLAND: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 188: SWITZERLAND: STABILITY TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 189: SWITZERLAND: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 190: SWITZERLAND: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 191: SWITZERLAND: VIROLOGY TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 192: SWITZERLAND: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 193: ROE: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 194: ROE: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 195: ROE: PHYSICAL CHARACTERIZATION TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 196: ROE: METHOD DEVELOPMENT AND VALIDATION SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 197: ROE: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 198: ROE: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 199: ROE: STABILITY TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 200: ROE: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 201: ROE: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 202: ROE: VIROLOGY TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 203: ROE: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 204: APAC: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 205: APAC: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 206: APAC: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 207: APAC: PHYSICAL CHARACTERIZATION TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 208: APAC: METHOD DEVELOPMENT AND VALIDATION SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 209: APAC: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 210: APAC: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 211: APAC: STABILITY TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 212: APAC: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 213: APAC: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 214: APAC: VIROLOGY TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 215: APAC: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 216: CHINA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 217: CHINA: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 218: CHINA: PHYSICAL CHARACTERIZATION TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 219: CHINA: METHOD DEVELOPMENT AND VALIDATION SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 220: CHINA: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 221: CHINA: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 222: CHINA: STABILITY TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 223: CHINA: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 224: CHINA: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 225: CHINA: VIROLOGY TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 226: CHINA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 227: JAPAN: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 228: JAPAN: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 229: JAPAN: PHYSICAL CHARACTERIZATION TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 230: JAPAN: METHOD DEVELOPMENT AND VALIDATION SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 231: JAPAN: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 232: JAPAN: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 233: JAPAN: STABILITY TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 234: JAPAN: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 235: JAPAN: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 236: JAPAN: VIROLOGY TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 237: JAPAN: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 238: INDIA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 239: INDIA: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 240: INDIA: PHYSICAL CHARACTERIZATION TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 241: INDIA: METHOD DEVELOPMENT AND VALIDATION SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 242: INDIA: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 243: INDIA: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 244: INDIA: STABILITY TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 245: INDIA: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 246: INDIA: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 247: INDIA: VIROLOGY TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 248: INDIA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 249: ROAPAC: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 250: ROAPAC: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 251: ROAPAC: PHYSICAL CHARACTERIZATION TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 252: ROAPAC: METHOD DEVELOPMENT AND VALIDATION SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 253: ROAPAC: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 254: ROAPAC: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 255: ROAPAC: STABILITY TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 256: ROAPAC: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 257: ROAPAC: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 258: ROAPAC: VIROLOGY TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 259: ROAPAC: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 260: LATIN AMERICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 261: LATIN AMERICA: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 262: LATIN AMERICA: PHYSICAL CHARACTERIZATION TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 263: LATIN AMERICA: METHOD DEVELOPMENT AND VALIDATION SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 264: LATIN AMERICA: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 265: LATIN AMERICA: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 266: LATIN AMERICA: STABILITY TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 267: LATIN AMERICA: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 268: LATIN AMERICA: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 269: LATIN AMERICA: VIROLOGY TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 270: LATIN AMERICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 271: MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 272: MIDDLE EAST & AFRICA: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 273: MIDDLE EAST & AFRICA: PHYSICAL CHARACTERIZATION TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 274: MIDDLE EAST & AFRICA: METHOD DEVELOPMENT AND VALIDATION SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 275: MIDDLE EAST & AFRICA: RAW MATERIAL TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 276: MIDDLE EAST & AFRICA: BATCH-RELEASE TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 277: MIDDLE EAST & AFRICA: STABILITY TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 278: MIDDLE EAST & AFRICA: MICROBIAL TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 279: MIDDLE EAST & AFRICA: ENVIRONMENTAL MONITORING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 280: MIDDLE EAST & AFRICA: VIROLOGY TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 281: MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 282: GROWTH STRATEGY MATRIX (2014-2017)
  • TABLE 283: ACQUISITIONS, 2014-2017
  • TABLE 284: EXPANSIONS, 2014-2017
  • TABLE 285: PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS, 2014-2017
  • TABLE 286: SERVICE LAUNCHES, 2014-2017

LIST OF FIGURES

  • FIGURE 1: RESEARCH DESIGN
  • FIGURE 2: DATA TRIANGULATION METHODOLOGY
  • FIGURE 3: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2018 VS. 2023 (USD MILLION)
  • FIGURE 4: DISSOLUTION TESTING TO REGISTER HIGHEST GROWTH DURING THE FORECAST PERIOD
  • FIGURE 5: PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES WILL CONTINUE TO DOMINATE THE MARKET DURING THE FORECAST PERIOD
  • FIGURE 6: GEOGRAPHIC SNAPSHOT OF HEALTHCARE ANALYTICAL TESTING SERVICES MARKET
  • FIGURE 7: GROWING FOCUS ON ANALYTICAL TESTING OF BIOLOGICS AND BIOSIMILARS TO DRIVE THE GROWTH OF THE MARKET IN 2017
  • FIGURE 8: PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES SEGMENT COMMANDED THE LARGEST MARKET SHARE IN 2017
  • FIGURE 9: INDIA AND CHINA TO REGISTER THE HIGHEST CAGR IN THE MARKET DURING THE FORECAST PERIOD
  • FIGURE 10: APAC TO REGISTER THE HIGHEST CAGR IN THE MARKET DURING THE FORECAST PERIOD
  • FIGURE 11: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: DRIVER, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 12: CONSOLIDATION AND LONG-TERM OUTSOURCING PARTNERSHIPS ARE LEADING INDUSTRY TRENDS
  • FIGURE 13: SERVICE SPONSOR OUTSOURCING RELATION TO TESTING VENDOR
  • FIGURE 14: BATCH-RELEASE TESTING SEGMENT TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD
  • FIGURE 15: CELL-BASED ASSAYS WILL CONTINUE TO DOMINATE THE BIOANALYTICAL TESTING SERVICES MARKET BY 2023
  • FIGURE 16: LASER PARTICLE SIZE ANALYSIS WILL CONTINUE TO DOMINATE THE PHYSICAL CHARACTERIZATION SERVICES MARKET DURING THE FORECAST PERIOD
  • FIGURE 17: US FDA DRUG RECALLS, BY CLASS AND YEAR (2010-2015)
  • FIGURE 18: PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES WILL CONTINUE TO DOMINATE THE MARKET IN 2023
  • FIGURE 19: R&D SPENDING OF PHRMA MEMBER COMPANIES, 1995-2015
  • FIGURE 20: BIOPHARMACEUTICAL PIPELINE, BY CATEGORY, 2016
  • FIGURE 21: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: GEOGRAPHIC SNAPSHOT (2018-2023)
  • FIGURE 22: NORTH AMERICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SNAPSHOT
  • FIGURE 23: PHARMACEUTICAL R&D EXPENDITURE IN THE US (2000-2015)
  • FIGURE 24: NUMBER OF FDA APPROVED MEDICINES, 2006-2015
  • FIGURE 25: NUMBER OF NEW CHEMICAL OR BIOLOGICAL ENTITIES (2002-2016)
  • FIGURE 26: EUROPE: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SNAPSHOT
  • FIGURE 27: BIOTECHNOLOGY AND PHARMACEUTICAL PATENT APPLICATIONS IN EUROPE, BY COUNTRY (2015)
  • FIGURE 28: ACQUISITION WAS THE MOST WIDELY ADOPTED GROWTH STRATEGY BY MARKET PLAYERS BETWEEN 2014 AND 2017
  • FIGURE 29: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SHARE ANALYSIS, BY KEY PLAYER, 2017
  • FIGURE 30: EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2016)
  • FIGURE 31: LABCORP: COMPANY SNAPSHOT (2016)
  • FIGURE 32: SGS: COMPANY SNAPSHOT (2017)
  • FIGURE 33: CHARLES RIVER: COMPANY SNAPSHOT (2016)
  • FIGURE 34: EXOVA: COMPANY SNAPSHOT (2016)
  • FIGURE 35: INTERTEK: COMPANY SNAPSHOT (2016)
  • FIGURE 36: MERCK: COMPANY SNAPSHOT (2016)
Back to Top